Inhibrx Biosciences, Inc.
(INBX - NASDAQ)
131,45 USD
📋 Profilo Aziendale

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

|